Evidence map›Paper›PMID 42882291›Full record

ReviewDiagnostics (Basel, Switzerland)2026

Ultrasound Imaging: A Cornerstone of the Entire High-Intensity Focused Ultrasound Tumor Treatment Continuum.

Yufeng Zhou

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yufeng ZhouState Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing 400016, China.ORCID 0000-0003-4086-2150

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-intensity focused ultrasound (HIFU) has emerged as a safe and effective tumor treatment modality, harnessing thermal effects to induce tissue coagulation, cavitation effects to cause liquefaction, or a synergistic combination of both mechanisms. As a widely adopted diagnostic tool, ultrasound imaging plays an integral role throughout the entire HIFU treatment continuum, encompassing tumor diagnosis, localization, procedural navigation, real-time intraprocedural monitoring, post-treatment outcomes evaluation, and long-term clinical follow-ups. This is attributed to its real-time imaging capability, low cost, non-ionizing nature, deep tissue penetration, and satisfactory resolution and sensitivity. Conventional B-mode sonography has been extensively employed for guiding HIFU treatment, yet it is constrained by notable technical limitations. To address these issues, a range of innovative ultrasound imaging approaches have been developed. A narrative review of the literature was conducted to systematically examine the functional roles and performance characteristics of these emerging techniques and to explore their potential for clinical translation as an integrated, multi-functional single system. Evidence demonstrates significant improvement of these novel ultrasound imaging technologies across various stages of HIFU treatment, particularly in temperature imaging and tissue characterization. With continued technological advancements and systematic integration, ultrasound imaging is poised to play an increasingly crucial role in optimizing the safety and efficacy of HIFU tumor treatment.

Indexed as

high-intensity focused ultrasound (HIFU)lesion monitoringsonography

Identifiers

PMID42882291
PMCPMC13664543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.